ODDB.org: Open Drug Database

Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung - 3 x 3 ml

Swissmedic Key	65041005 PP	Registration Holder	Novo Nordisk Pharma AG
Name	Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml, Injektionslösung	Date of registration	12.09.2014
		Introduction of Sequence	12.09.2014
ATC-Classification	Insulin Degludec and Liraglutide (A10AE56)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.06.10.	Show package size	3 x 3 ml
Index Therapeuticus (Swissmedic)	07.06.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	116.91	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	150.75
Feedback	FB
GTIN	7680650410058	Medication Code	Biotechnologika
Pharmacode	6521415	Disponibility

Composition

insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., liraglutidum 3.6 mg, phenolum, glycerolum, zincum ut zinci acetas dihydricus, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 0.0416 mmol, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Insulinum Degludecum	600
Liraglutidum	3.6 mg/ml
Nmol

BAG: Active Agent	Dose
Insulinum Degludecum	100 U
Liraglutidum	3.6 mg

Inactive agents
Acidum Hydrochloridum
Glycerol
Sodium Hydroxide
Phenol
Zincum

Source

Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2024	©ywesee GmbH